1. Home
  2. SLDP vs ATYR Comparison

SLDP vs ATYR Comparison

Compare SLDP & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Power Inc.

SLDP

Solid Power Inc.

HOLD

Current Price

$2.92

Market Cap

714.7M

Sector

Energy

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.75

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDP
ATYR
Founded
2011
2005
Country
United States
United States
Employees
230
58
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.7M
73.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SLDP
ATYR
Price
$2.92
$0.75
Analyst Decision
Strong Buy
Hold
Analyst Count
2
8
Target Price
$7.00
$4.20
AVG Volume (30 Days)
3.1M
985.5K
Earning Date
05-05-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.64
52 Week High
$8.86
$7.29

Technical Indicators

Market Signals
Indicator
SLDP
ATYR
Relative Strength Index (RSI) 30.18 37.34
Support Level N/A $0.67
Resistance Level $3.48 $0.85
Average True Range (ATR) 0.16 0.05
MACD 0.02 -0.01
Stochastic Oscillator 4.10 1.23

Price Performance

Historical Comparison
SLDP
ATYR

About SLDP Solid Power Inc.

Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: